Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

Vertex gains FDA fast track designation for diabetes stem cell therapy

Vertex gains FDA fast track designation for diabetes stem cell therapy

Vertex says VX-880 has potential to restore pancreatic islet cell function, including insulin production, in type 1 diabetes patients. ... The US Food and Drug Administration (FDA) has granted Vertex’s investigational stem cell therapy VX-880 a fast

Latest news

  • Calliditas bets on PBC drug in Genkyotex buyout Calliditas bets on PBC drug in Genkyotex buyout

    The drug is also being evaluated in a phase 2 clinical trial in type 1 diabetes and kidney disease, and a further phase 2 trial of the drug in IPF is ... A further 10m will be payed following the approval by the FDA or EC in either idiopathic pulmonary

  • Key emerging trends in digital health Key emerging trends in digital health

    An exciting development for those living with type 1 diabetes comes from Abbott, a glucose sensing technology company, and Insulet, a diabetes medical device company, who have partnered to develop integrated ... A new start-up app, named Quin, is also

  • FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

    Last July the FDA also turned down AstraZeneca’s filing for Farxiga in type 1 diabetes, although the drug has been approved in this indication in Europe and Japan. ... The challenges of managing blood sugar levels for those with type 1 diabetes, and

  • Vertex reveals promising data from first CRISPR-treated patients Vertex reveals promising data from first CRISPR-treated patients

    and to continue to accelerate our gene-editing programs for other serious diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1,” he added. ... The American pharma giant also acquired Semma Therapeutics in September, which is

  • FDA advisors say no to empagliflozin in type 1 diabetes FDA advisors say no to empagliflozin in type 1 diabetes

    That means Boehringer and Lilly now have to decide whether approval in type 1 diabetes is worth the cost of running another trial. ... If they do eventually get approval the intention is to sell the drug for type 1 diabetes under a separate brand name.

More from news
Approximately 12 fully matching, plus 138 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    Examples of this approach include developing statins for the treatment of dyslipidemia, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for hypertension, and glucagon-like peptide 1 ... 1) receptor agonists for

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    In one example, Provention Bio was forced to temporarily pause a phase 3 study evaluating its investigational therapy for type 1 diabetes. ... Endpoint type – any endpoint that can only be assessed in person or using hospital infrastructure or

  • Growing up as a patient is hard to manage Growing up as a patient is hard to manage

    Chronic diseases and their treatments in general place varying degrees of psychological and behavioural demands on adolescents but there is evidence of rates of adherence differing by disease type, suggesting that ... For adolescents with type 1 diabetes,

  • The fight for affordable insulin The fight for affordable insulin

    After years of steeply rising prices, the issue has hit the national consciousness in the US, and people with type 1 diabetes and their families are taking direct action and coming ... T1International. Elizabeth Pfiester is the founder of T1International,

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    The most heartfelt category of the evening was undoubtedly The People’s Award, which was presented to Beth Baldwin, who lost her son at age 13 to undiagnosed type 1 diabetes ... type 1 diabetes.

More from intelligence
Approximately 2 fully matching, plus 23 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy  ... one diabetes (T1D) patients and at-risk individuals and, in

  • JDRF names new CEO JDRF names new CEO

    Derek Rapp to lead diabetes research charity. The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mednet Group Mednet Group

    For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. ... Including a case study showing the perspective of a young person newly

  • The importance of health literacy in patient recruitment materials

    Figure 1. Type 2 Diabetes (top) and Cancer (bottom) posters that were presented. ... Most appreciated a short and snappy headline, with a positive and upbeat message behind it (Figure 1).

  • Covid-19: what could it mean for the diabetic population?

    body. For those with type 1 diabetes, a condition called Diabetic Ketoacidosis (DKA), is a particular risk if the body starts to run out of insulin. ... vision to prevent type 2 diabetes and even achieve remission for some patients.

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Including a case study showing the perspective of a young person newly diagnosed with type 1 diabetes. ... and Turner, H.M., 2005. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes.

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

How a design mindset can lead to better medical outcomes
By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...

Infographics